391 related articles for article (PubMed ID: 24456252)
1. Synthesis and cytotoxic activities of a series of novel N-methyl-bisindolylmaleimide amide derivatives.
Wang K; Liu ZZ
J Asian Nat Prod Res; 2014; 16(3):296-303. PubMed ID: 24456252
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of N-methyl-bisindolylmaleimide amino acid methyl ester conjugates and cytotoxicity study.
Wang K; Liu ZZ
Eur J Med Chem; 2010 Sep; 45(9):4175-9. PubMed ID: 20598779
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antitumor activity of bisindolylmaleimide and amino acid ester conjugates.
Wang K; Li XY; Chen XG; Liu ZZ
J Asian Nat Prod Res; 2010 Jan; 12(1):36-42. PubMed ID: 20390741
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of novel 7-azaindazolyl-indolyl-maleimide derivatives as antitumor agents and protein kinase C inhibitors.
Ye Q; Cao J; Zhou X; Lv D; He Q; Yang B; Hu Y
Bioorg Med Chem; 2009 Jul; 17(13):4763-72. PubMed ID: 19447039
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and cytotoxicity of novel 3-amino-4-indolylmaleimide derivatives.
Zhao SY; Yang YW; Zhang HQ; Yue Y; Fan M
Arch Pharm Res; 2011 Apr; 34(4):519-26. PubMed ID: 21544716
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of novel bisindolylmaleimides that inhibit vascular endothelial cell proliferation.
Braña MF; Añorbe L; Tarrasón G; Mitjans F; Piulats J
Bioorg Med Chem Lett; 2001 Oct; 11(20):2701-3. PubMed ID: 11591505
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationship of N-methyl-bisindolylmaleimide derivatives as cell death inhibitors.
Katoh M; Dodo K; Fujita M; Sodeoka M
Bioorg Med Chem Lett; 2005 Jun; 15(12):3109-13. PubMed ID: 15896957
[TBL] [Abstract][Full Text] [Related]
8. "On water" expedient synthesis of 3-indolyl-3-hydroxy oxindole derivatives and their anticancer activity in vitro.
Sai Prathima P; Rajesh P; Venkateswara Rao J; Sai Kailash U; Sridhar B; Mohan Rao M
Eur J Med Chem; 2014 Sep; 84():155-9. PubMed ID: 25016373
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and pharmacological evaluation of novel bisindolylalkanes analogues.
Song YL; Dong YF; Yang T; Zhang CC; Su LM; Huang X; Zhang DN; Yang GL; Liu YX
Bioorg Med Chem; 2013 Dec; 21(24):7624-7. PubMed ID: 24262885
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach.
Preti D; Romagnoli R; Rondanin R; Cacciari B; Hamel E; Balzarini J; Liekens S; Schols D; Estévez-Sarmiento F; Quintana J; Estévez F
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1225-1238. PubMed ID: 30141353
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and antiproliferative activity of novel aminosubstituted benzothiopyranoisoindoles.
Christodoulou A; Kostakis IK; Kourafalos V; Pouli N; Marakos P; Trougakos IP; Tsitsilonis OE
Bioorg Med Chem Lett; 2011 May; 21(10):3110-2. PubMed ID: 21444205
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antiproliferative activity of the ring system [1,2]oxazolo[4,5-g]indole.
Barraja P; Caracausi L; Diana P; Spanò V; Montalbano A; Carbone A; Parrino B; Cirrincione G
ChemMedChem; 2012 Nov; 7(11):1901-4. PubMed ID: 22915307
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and antiproliferative activity of a novel class of indole-2-carboxylate derivatives.
Ji XY; Xue ST; Zhan YC; Shen JJ; Wu LT; Jin J; Wang Z; Li ZR
Eur J Med Chem; 2014 Aug; 83():409-18. PubMed ID: 24996136
[TBL] [Abstract][Full Text] [Related]
14. 4- and 5-aroylindoles as novel classes of potent antitubulin agents.
Liou JP; Wu CY; Hsieh HP; Chang CY; Chen CM; Kuo CC; Chang JY
J Med Chem; 2007 Sep; 50(18):4548-52. PubMed ID: 17685504
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and preliminary evaluation of 3-thiocyanato-1H-indoles as potential anticancer agents.
Fortes MP; da Silva PB; da Silva TG; Kaufman TS; Militão GC; Silveira CC
Eur J Med Chem; 2016 Aug; 118():21-6. PubMed ID: 27116711
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and cytotoxicity of indolopyrrolemaleimides.
Xu GQ; Guo P; Zhang C; He QJ; Yang B; Hu YZ
Chem Pharm Bull (Tokyo); 2007 Sep; 55(9):1302-7. PubMed ID: 17827752
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and anti-tumor activity of 2-amino-3-cyano-6-(1H-indol-3-yl)-4-phenylpyridine derivatives in vitro.
Zhang F; Zhao Y; Sun L; Ding L; Gu Y; Gong P
Eur J Med Chem; 2011 Jul; 46(7):3149-57. PubMed ID: 21514012
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of novel phenylcarbazoles as potential anticancer agents.
Routier S; Mérour JY; Dias N; Lansiaux A; Bailly C; Lozach O; Meijer L
J Med Chem; 2006 Jan; 49(2):789-99. PubMed ID: 16420063
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of 1-(4'-Indolyl and 6'-Quinolinyl) indoles as a new class of potent anticancer agents.
Lai MJ; Chang JY; Lee HY; Kuo CC; Lin MH; Hsieh HP; Chang CY; Wu JS; Wu SY; Shey KS; Liou JP
Eur J Med Chem; 2011 Sep; 46(9):3623-9. PubMed ID: 21641700
[TBL] [Abstract][Full Text] [Related]
20. From a natural product lead to the identification of potent and selective benzofuran-3-yl-(indol-3-yl)maleimides as glycogen synthase kinase 3beta inhibitors that suppress proliferation and survival of pancreatic cancer cells.
Gaisina IN; Gallier F; Ougolkov AV; Kim KH; Kurome T; Guo S; Holzle D; Luchini DN; Blond SY; Billadeau DD; Kozikowski AP
J Med Chem; 2009 Apr; 52(7):1853-63. PubMed ID: 19338355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
